FDA Inspection 1140365 — Domenica Rubino, MD
The FDA completed an inspection of Domenica Rubino, MD on March 26, 2021 in Arlington, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 26, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Arlington, VA (United States)
Additional Details
Clinical Investigator (CI)